BLAKE WEIMER: Open Payments
NPI 1023732443 · LAGRANGE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$719 in 38 payments from 12 companies in 2025. Trend: 2023 $267 · 2024 $771 · 2025 $719
Food & beverage: $719
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $229 |
| Novo Nordisk Inc | 5 | $96 |
| AstraZeneca Pharmaceuticals LP | 5 | $93 |
| Axsome Therapeutics, Inc. | 4 | $71 |
| Exact Sciences Corporation | 3 | $46 |
| Lilly USA, LLC | 2 | $42 |
| GlaxoSmithKline, LLC. | 2 | $30 |
| Inspire Medical Systems, Inc. | 1 | $28 |
| Eisai Inc. | 1 | $26 |
| Dexcom, Inc. | 1 | $22 |
Products named: QULIPTA, FARXIGA, Auvelity, VRAYLAR, VIBERZI, Cologuard Collection Kit, TRELEGY ELLIPTA, INSPIRE.
Industry payments across IN — which companies pay providers there.
